SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-146203
Filing Date
2023-05-16
Accepted
2023-05-16 17:21:02
Documents
15
Period of Report
2023-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d502216d8k.htm   iXBRL 8-K 31059
2 EX-1.1 d502216dex11.htm EX-1.1 169682
3 EX-5.1 d502216dex51.htm EX-5.1 8761
7 GRAPHIC g502216g0516055537850.jpg GRAPHIC 2668
  Complete submission text file 0001193125-23-146203.txt   390588

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20230516.xsd EX-101.SCH 2845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20230516_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20230516_pre.xml EX-101.PRE 11255
9 EXTRACTED XBRL INSTANCE DOCUMENT d502216d8k_htm.xml XML 3351
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 23928744
SIC: 2836 Biological Products, (No Diagnostic Substances)